Public Summary Document Application No. 1466 – Decision
In 2016, IRSA applied to MSAC to restore public funding for a selected patient group likely to benefit from early vertebroplasty. The application was based on the VAPOUR trial.
We are pleased to announce MSAC has supported the application for the patient subgroup in the VAPOUR trial who showed greatest benefit from vertebroplasty. The decision is published on the MSAC website as a Public Summary Document (PSD).
... read more.
Road Map for Advancing IR and INR in Australia and New Zealand
In March 2019, the Interventional Radiology Committee released a white paper on Interventional Radiology for consultation to College members and other key stakeholders. The document was developed with the purpose of informing the College membership and stakeholder groups of the current and long-term positioning of IR and INR in Australia and New Zealand.
... read more.
CIRSE-COVID-19 Resource Centre
The CIRSE publications department have put together a range of useful links and resources for reference during the COVID-19 crisis.
... read more.
Latest TGA statement on paclitaxel-coated products
IRSA would like to inform it’s members of the latest TGA statement on paclitaxel-coated products used in the peripheral arteries.
... read more.
Consensus Guidelines on anticoagulants in IR
IRSA would like to highlight the recent update on the consensus guidelines on anticoagulants in interventional radiology published in JVIR. These are excellent and comprehensive
... read more.
Popular Posts
January 16, 2026
December 22, 2025
Doctor Finder
Our Doctor Finder is a comprehensive database of interventional radiologists practicing in Australasia. Use the search fields to search based on geographic location or by area of practice.